Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
Research output: Patent
The present invention describes a method for determining whether an individual is suffering from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.
Original language | English |
---|---|
Patent number | US 2003/0082652 A1 |
Filing date | 08/04/2002 |
Publication status | Published - 2002 |
Bibliographical note
U.S. Classification 435007230 International Classification G01N033/574
ID: 40181454